GlassScriptPhysician profile
Bradley P Grayum
NPI 1831250992
$662.69
in general payments reported to CMS, 2019-2025
16 companies · $373 in 2025
The $373 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $105 · 2023: $14.35 · 2024: $58.95 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $90.36 | 2024-2025 | |
| Ucb, INC. | $84.11 | 2019-2025 | Fintepla, Nayzilam, Rystiggo |
| Biogen, INC. | $72.61 | 2025 | Vumerity, Tysabri |
| Teva Pharmaceuticals USA, INC. | $67.86 | 2019-2025 | Austedo Xr |
| Neurocrine Biosciences, INC. | $60.83 | 2024-2025 | Ingrezza |
| Alexion Pharmaceuticals, INC. | $58.97 | 2020 | |
| Csl Behring | $41.54 | 2024-2025 | Hizentra |
| Amgen INC. | $37.85 | 2019-2025 | Uplizna |
| Janssen Biotech, INC. | $35.83 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2020 | |
| Argenx US, INC. | $16.94 | 2025 | Vyvgart Hytrulo, Vyvgart |
| Allergan, INC. | $16.58 | 2020 | |
| Genentech USA, INC. | $14.57 | 2019 | |
| Lundbeck LLC | $12.76 | 2019 | |
| Alnylam Pharmaceuticals INC. | $11.24 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Grayum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.